Up-284

N/A

Report date: 2024/11/13 15:02:22

Base Information

Drug NameUp-284
Drug Alias NameUp-284
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasomal ubiquitin receptor ADRM1 antagonists
TargetsProteasomal ubiquitin receptor ADRM1
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUp Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesUp Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A